Mike McDermott, chief global supply officer and executive vice-president at the pharmaceutical giant, said the company had a very strong development pipeline for new products, which needed flexible facilities.
“Our pipeline is incredibly strong, and we need facilities that can accept that pipeline and are nimble ...
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: